Seminare

Seminare 2018-08-09T11:12:56+00:00

Aktuelle Seminare des Sonderforschungsbereiches 900

Aktuelle Seminare

Jeden ersten Donnerstag im Monat findet unsere SFB 900 Seminarreihe statt. Folgende Gastsprecher werden in den nächsten Monaten im SFB 900 Seminar ihre Forschung vorstellen. Bitte beachten Sie in diesem Zusammenhang auch unsere regelmäßig veranstalteten Symposien. Informationen zu unseren Forschungsprojekten finden Sie auf den jeweiligen Projektseiten.

Aktuelle Ankündigung
  • 23.08.2018 Dr. Emanuel Wyler, Max Delbrück Center for Molecular Medicine, Berlin, Germany

  • 06.09.2018 Prof. Philip Goulder, Department of Paediatrics, Medical Sciences Division, University of Oxford, UK

  • 04.10.2018 Prof. Dmitriy Chudakov, Head of Genomics of Adaptive Immunity Department, Institute of Bioorganic Chemistry, Moscow, Russia

  • 06.12.2018 Prof. Hinrich Schulenburg, Evolutionary Ecology and Genetics, University of Kiel, Germany

Vergangene Seminare des Sonderforschungsbereiches 900

Vergangene Seminare

02.02.2017

Dr. David Vermijlen Institute for Medical Immunology, Université Libre de Bruxelles, Brussels, Belgium

“Immunity in early life: the case of human gammadelta T cells”

06.04.2017

Prof. Olivier Schwartz Head of Virus und Immunity Unit, Department of Virology, Institut Pasteur, Paris, France

“Viral replication and immune responses: HIV and ZIKA”

04.05.2017

Prof. Urs Greber, Department of Molecular Life Science, University of Zürich, Switzerland

“Virus & Cell Mechanics in Entry & Uncoating”

01.06.2017

Prof. Stacey Efstathiou, Viral Vaccines, The National Institute for Biological Standards and Control (NIBSC), South Mimms, UK

“The ‚Ins and Outs‘ of herpes simplex virus latency”

08.06.2017

Prof. Thomas Gramberg, Department of Virology, Universitätsklinikum Erlangen

“The role of SAMHD1 in fending off Retroviruses and endogenous Retroelements”

14.08.2017

Prof. Pierre Guermonprez, Department of Immunobiology, King`s College London, UK

“Monocyte heterogeneity and function”

23.08.2017

Ass. Prof. Jeff Rathmell, Department of Pharmacology and Cancer Biology, Duke University School of Medicine, USA

“Fueling T cells in Inflammation and Tumors”

30.08.2017

Dr. Agnes Wiedemann, INRA, Université Francois-Rabelais, Tours, France

“An updated view on Salmonella invasion mechanisms: still much to discover“

Flyer Agnes Wiedemann

07.09.2017

Dr. Cécile Arrieumerlou, Cochin Institute, Paris, France

„ALPK1 controls TIFA/TRAF6-dependent innate immunity against heptose-1,7-bisphosphate of gram-negative bacteria“

Flyer Cecile Arrieumerlou

05.10.2017

Dr. Cesar Munoz Fontela, HPI Hamburg

„The APC-T cell interface during Ebola virus infection“

Flyer Cesar Munoz-Fontela

07.01.2016

Dr. Stéphane Roche Group „Cryo-electron microscopy and X-ray crystallography correlative structural virology“, Institute for Integrative Biology of the Cell (I2BC), Gif-sur-Yvette, France

“A structural characterization of the large tegument protein of Herpes Simplex Virus 1”

04.02.2016

Prof. Jürgen Ruland Institute of Clinical Chemistry and Pathobiochemistry, Technical University Munich, Germany

“C-type Lectin Receptor Signaling in the Innate Immune System”

01.04.2016

Prof. Dr. Tohru Minamino Graduate School of Frontier Biosciences, Osaka University, Japan

“Flagellar type III protein export in Salmonella and the role of chaperones”

04.04.2016

Dr. Lüder Wiebusch Laboratory of Pediatric Molecular Biology, Charité – Universitätsmedizin Berlin, Germany

“Different approaches, one target: cell cycle arrest mechanisms of human and mouse cytomegaloviruses”

12.05.2016

Dr. Noam Stern-Ginossar Department of Molecular Genetics, Weizmann Institute of Science Rehovot, Israel

“Decoding viral infection with ribosome profiling”

19.05.2016

Prof. Ulf Dittmer Institute of Virology, Universitätsklinikum Essen, Essen, Germany

“The role of IFNa subtypes in anti-retroviral immunity”

30.05.2016

Dr. Luisa Stroeh Group Prof. Dr. Thilo Stehle, Interfaculty Institute of Biochemistry, University of Tübingen, Germany

“Structural Analysis and Glycan Receptor Specificities of Human Polyomaviruses”

02.06.2016

Prof. Jacques Fellay Global Health Institute École polytechnique fédérale de Lausanne (EPFL), Lausanne, Switzerland

“Human genomics of viral diseases”

07.07.2016

Assist. Prof. Marcel de Zoete Dept. Of Infectious Diseases and Immunology, Utrecht University, The Netherlands

“IgA leads the way – Identifying pathogenic commensals in inflammatory bowel disease”

16.08.2016

Dr. Paola Romagnoli Inserm U1043, Toulouse, France

“Life cycle of regulatory T lymphocytes”

18.08.2016

Prof. Florent Ginhoux A*Star Singapore, Singapore Immunology Network

“Dendritic cell and Macrophage Biology: from development to functions”

01.09.2016

Dr. Maria Teresa Catanese King’s College London, School of Medicine Department of Infectious Diseases London, UK

“Structure and composition of hepatitis C virus: Novel insights into virus-host interactions required for propagation of infection”

06.10.2016

Dr. Andreas Pichlmair Max Planck Institute of Biochemistry Martinsried, Germany

“Virus-Host interactions: From specific interactions to general mechanisms”

18.10.2016

Dr. Nicolas Suarez Centre for Virus Research (CVR), MRC-University of Glasgow, Glasgow, Scotland

“Sequencing Human Cytomegalovirus Genomes Directly from Clinical Material: Challenges and Opportunities”

19.10.2016

Dr. Sandrine Henri Lab. Bernard & Marie MALISSEN, Centre d’Immunologie de Marseille-Luminy (CIML), Marseille, France

“Complexity of the mononuclear phagocytic system of the skin: from phenotype to functions to vaccine”

03.11.2016

Prof. Félix A. Rey Head of Structure, Structural Virology, Department of Virology, Institut Pasteur, Paris, France

“Structural studies indicate a path for developing a single vaccine protecting simultaneously against dengue and Zika viruses”

01.12.2016

Dr. Michael Weekes Wellcome Trust Senior Clinical Fellow Honorary Consultant in Infectious Diseases, Addenbrooke’s Hospital Cambridge, Institute for Medical Research (CIMR), University of Cambridge, UK

“New insights into immune evasion by human herpesviruses from quantitative multiplexed proteomics”

05.03.2015

Prof. Dr. Ulrike Protzer Director of Institute of Virology, Technical University of Munich / Helmholtz Zentrum München – German Center for Environmental Health, Germany

“Immune Control of Hepatitis B Virus”

26.03.2015

Prof. Dr. Thomas Stamminger Group leader

“Human Cytomegalovirus Gene Regulation”, Institute of Virology, Friedrich-Alexander-University Erlangen-Nürnberg, Germany
“Innate antiviral defense by PML nuclear bodies”

07.05.2015

Prof. Dr. Jürgen Ruland Head of the Institute of Clinical Chemistry and Pathobiochemistry, TUM School of Medicine, Munich, Germany

“Pattern Recognition Receptor signaling in anti-fungal Immunity”

04.06.2015

Prof. Juan Martin-Serrano Professor of Viral Cell Biology Department of Infectious Diseases, King’s College London School of Medicine, UK

“Controlling the ESCRT machinery in cell biology and viral pathogenesis”

02.07.2015

Prof. Dr. Anne Müller Institute of Molecular Cancer Research, University of Zurich, Switzerland

“Helicobacter pylori in health and disease”

09.07.2015

Prof. Adrian Whitehouse Professor of Molecular Virology, School of Molecular and Cellular Biology, University of Leeds, UK

“Targeting a novel mechanism of KSHV-induced genomic instability: a novel antiviral approach”

21.07.2015

Dr. Jorge Ruben Cabrera Centro de Biología Molecular Severo Ochoa, Madrid, Spain

“Secreted Herpes Simplex Virus-2 glycoprotein G, NGF, axonal growth and pain”

23.07.2015

Prof. Michael Roggendorf Institute of Virology, Technical University Munich, Germany

“Prime/Boost Therapeutic Vaccination against Chronic Hepatitis B: precinical Studies and Perspectives for the Treatment of Patients”

23.07.2015

Prof. Guntram Graßl Institute of Medical Microbiology and Hospital Hygiene, Hannover Medical School, Germany

“Proteases in chronic Salmonella infections”

03.09.2015

Prof. Wensheng Wei PI of BIOPIC, Center for Life Sciences and School of Life Sciences, Peking University, China

“Genome editing and human disease – have you CRISPRed?”

01.10.2015

Prof. Joseph Sun Assistant Professor of Immunology, Memorial Sloan Kettering Cancer Center, Weill Cornell Medical College, New York, USA

“Immunological memory in natural killer cells”

16.10.2015

Prof. Karen Mossman Professor at the Department of Pathology and Molecular Medicine,McMaster Immunology Research Centre, McMaster University, West Hamilton, Canada

“Novel intrinsic/innate pathways that sense the “stress” of viral infections”

18.11.2015

Prof. Dr. Blossom Damania Boshamer Distinguished Professor of Microbiology & Immunology, University of North Carolina at Chapel Hill, USA

“KSHV encoded viral homologs: Roles in cell survival, migration, and immune evasion”

19.11.2015

Prof. Sebastian Springer Associate Professor of Biochemistry and Cell Biology, Department of Life Sciences and Chemistry, Jacobs University Bremen, Germany

“The murine cytomegalovirus immunoevasin gp40/m152 binds MHC class I molecules to retain them in the early secretory pathway”

20.11.2015

Dr. Ouyang Cyagen Biosciences Inc., Santa Clara, USA

“CRISPR/Cas9 and TurboKnockout: Technologies for Rapid Generation of Knockout/Knockin Mouse Models”

27.11.2015

Prof. John Sinclair Professor of Molecular Virology, University of Cambridge, Department of Medicine, Cambridge, UK

“Human cytomegalovirus latency results in profound cellular changes which can be targeted with novel therapeutics”

03.12.2015

Dr. Dirk Grimm Leader of CellNetworks Research Group „Virus-host interactions“, Heidelberg University Hospital, Germany

“Small viruses + tiny RNAs = a giant toolbox for gene & cell therapy”

09.01.2014

Prof. Christine Carrington-Kravatzky Department of Preclinical Sciences Faculty of Medical Sciences, The University of the West Indies, The Carribean

“Phylogeography and population dynamics of Dengue viruses in the Americas”

20.02.2014

Dr. Claudia Kemper MRC Centre for Transplantation, King´s College London, UK

“Unexpected novel roles for innate immunity in human Th1”

06.03.2014

Dr. Antonio Alcami Centro de Biología Molecular Severo Ochoa, Universidad Autónoma de Madrid, Spain

“Poxvirus TNF and chemokine decoy receptors: what can we learn from them?”

24.04.2014

Prof. Peter Stäheli Institute for Virology, Department of Medical Microbiology and Hygiene, University Medical Center Freiburg, Germany

“Uncovering the role of Interferon-lambda in antiviral defense”

30.04.2014

Dr. Ariberto Fassati Head of Wohl Virion Centre, Division of Infection and Immunity, University College London, UK

“Heat shock protein 90 controls HIV-1 gene expression”

08.05.2014

Dr. Martin Rottenberg Department of Microbiology, Karolinska Institute Stockholm, Sweden

“Role of SOCS proteins in the outcome of Tuberculosis”

05.06.2014

PD Dr. Christian Sina Universitätsklinikum Schleswig-Holstein, Lübeck

“Circadian clock function maintains mucosal homeostasis in the gut”

26.06.2014

Dr. Thomas Gebhardt Department for Microbiology and Immunology, The University of Melbourne, Peter Doherty Institute for Infection and Immunity, Parkville, Australia

“Antiviral T-cell immunity in skin”

04.09.2014

Dr. Olivier Neyrolles CNRS Research director Institute of Pharmacology and Structural Biology, Tuberculosis and Infection Biology department, CNRS Toulouse, France

“Inflammation and control of inflammation in tuberculosis”

04.12.2014

Dr. Julie Déchanet-Merville Composantes Innées de la Réponse Immunitaire et de la Différenciation, Université Bordeaux, France

“Control of CMV infection by gamma-delta T cells recognizing self stress antigens”

11.12.2014

Dr. Felix Meissner Department of Proteomics and Signal Transduction, Max Planck Institute of Biochemistry, Martinsried, Germany

“Proteomics of secreted proteins defines how proximal adaptors of TLRs regulate inflammation”

11.04.2013

Prof. Jürgen Haas Division of Pathway Medicine, University of Edinburgh, Scotland

“Genetic determinants of HSV-1 reactivation”

10.10.2013

Prof. Stephen Goff Howard Hughes Medical Institute, Columbia University Medical Center, New York, USA

“Players in the Silencing of Retroviral DNAs in Embryonic Stem Cells”

17.10.2013

Prof. Cecilia Söderberg-Nauclér Department of Medicine, Karolinska Institute, Stockholm, Schweden

“The role of CMV in tumors – New possibilities for treatment options?”

07.11.2013

Dr. Jason Mercer Institute of Biochemistry, ETH Zürich, Switzerland

“From Screen to Gene: Unraveling the Mystery of Poxvirus Genome Uncoating”

05.12.2013

Prof. Jonathan Ball School of Life Sciences and Nottingham Digestive Diseases, Centre Biomedical Research Unit, The University of Nottingham, UK

“Mimicking the neutralising face of the HCV E2 glycoprotein: The antibody-based vaccine challenge”

02.02.2012

Prof. Hartmut Hengel Institute of Virology, Heinrich Heine University, Düsseldorf

“Modulation of immune receptors by human cytomegalovirus”

04.04.2012

Prof. Thomas Borén Department Medical Biochemistry and Biophysics Umeå University, Umeå, Sweden

“Helicobacter pylori; multitalented adaptation of binding properties”

15.05.2012

Dr. Ramon Arens Department of Immunohematology and Blood Transfusion, Leiden University Medical Center, The Netherlands

“Rational Design of Vaccines: Learning from Immune Evasion Mechanisms of Persistent Viruses”

14.06.2012

Prof. Greg Towers Centre for Medical Molecular Virology, Division of Infection and Immunity, University College London, UK

“Going under the radar with HIV: Host Virus Interactions and Innate Immunity”

12.07.2012

Prof. Paul Kellam The Wellcome Trust Sanger Institute, Hinxton, Cambridge, UK

“Host and virus genetics of pandemic H1N1/09 influenza A virus”

10.09.2012

Prof. Karen Mossman Department of Pathology and Molecular Medicine, McMaster University, Hamilton, Ontario, Canada

“Novel antiviral innate immune responses”

04.10.2012

Prof. Wolfram Brune Heinrich-Pette-Institute Leibniz Institute for Experimental Virology, Hamburg

“Modulation of the unfolded protein response by cytomegalovirus”

01.11.2012

Dr. Leif E. Sander Medical Department, Division of Infectiology and Pneumonology, Charité Berlin

“Innate Immune Sensing of Infectious Threats”

15.11.2012

Dr. Mario Schelhaas Emmy Noether Research Group: Virus Endocytosis, Westphalian Wilhelms-University of Münster

“The entry of oncogenic Human Papillomaviruses – a baroque dance with multiple host factors culminating in nuclear import during mitosis”

22.11.2012

Prof. Moriah Szpara Department of Molecular Biology, Princeton University, Pennsylvania State, USA

“Genetic Variation and Neurovirulence in Alpha-Herpesviruses” 06.12.2012 Dr. Hartmut Hengel Department of Virology, University Medical Center Freiburg “Cytomegalovirus immune escape and persistence”

07.02.2011

Dr. Eva Medina Head of the „Infection Immunology Research Group“ Department of Medical Microbiology, Helmholtz Centre for Infection Research (HZI), Braunschweig

„Small colony variants and the host immune response during persistent Staphylococcus aureus infection: Who’s governing, and who’s the governed?“

05.09.2011

Prof. Theo Geijtenbeek Dept. of Mol. Cell Biology & Immunology, VU Medical Centre, Amsterdam

“C-type lectins in infection and immunity”

01.12.2011

Prof. Michael S. Diamond Professor of Internal Medicine, Division of Infectious Diseases, Washington University in St. Louis, School of Medicine

“New Insights into Innate and Adaptive Immune Control of Flavivirus Infection”